Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

72 insider filings · Latest: Sep 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 18, 2026Sep 22 9:01 PMBrian SavageInterim Chief Legal Officer
Sale
7,342$38.85$285.2K8,500(D)

View →

Sep 18, 2026Sep 22 8:21 PMRoberto MignoneDirector
Sale
367,600$39.06$14.4M0(I)

View →

Sep 18, 2026Sep 21 10:40 AMSavage Brian
Proposed Sale
7,028$38.85$273.1K—

View →

Sep 18, 2026Sep 18 9:00 PMBridger Management, LLC (1)
Proposed Sale
367,600$39.19$14.4M—

View →

Aug 21, 2026Aug 25 8:05 PMAmir WeissChief Accounting Officer
Sale
9,445$37.62$355.3K13,071(D)

View →

Aug 21, 2026Aug 25 8:03 PMRonit Satchi-FainaroDirector
Sale
415$37.25$15.5K111,986(D)

View →

Aug 17, 2026Aug 19 8:00 PMEvan LippmanEVP, Business Development
Sale
18,600$36.57$680.3K25,591(D)

View →

Aug 17, 2026Aug 17 8:00 PMLippman Evan
Proposed Sale
18,600$36.57$680.3K—

View →

Aug 5, 2026Aug 10 10:07 AMTal Zvi ZaksDirector
Sale
17$34.87$59373,247(D)

View →

Aug 3, 2026Aug 5 8:04 PMPlacid JoverSee "Remarks"
Sale
12,827$34.88$447.4K6,774(D)

View →

Aug 3, 2026Aug 5 8:02 PMEric A HughesSee "Remarks"
Sale
25,578$34.88$892.1K134,877(D)

View →

Aug 3, 2026Aug 3 8:01 PMHughes Eric A
Proposed Sale
25,578$34.88$892.1K—

View →

Aug 3, 2026Aug 3 8:00 PMJover Placid
Proposed Sale
12,827$34.88$447.4K—

View →

Jun 18, 2026Jun 22 8:00 PMMatthew ShieldsEVP, Global Operations
Sale
9,989$32.19$321.5K0(D)

View →

Jun 18, 2026Jun 18 8:14 PMShields Matthew
Proposed Sale
9,989$32.19$321.5K—

View →

Jun 11, 2026Jun 16 12:28 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
106,563$34.10$3.6M65,621(D)

View →

Jun 11, 2026Jun 11 8:00 PMKalif Eliyahu Sharon
Proposed Sale
106,563$34.10$3.6M—

View →

Jun 5, 2026Jun 8 8:01 PMRichard D FrancisPresident and CEO
Sale
6,153$34.35$211.4K1,177,529(D)

View →

Jun 5, 2026Jun 5 8:00 PMFrancis Richard D
Proposed Sale
6,153$34.35$211.4K—

View →

Jun 3, 2026Jun 4 8:00 PMMatthew ShieldsEVP, Global Operations
Sale
16,195$32.87$532.3K9,989(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 28, 2026Jun 1 8:08 PMRosemary A CraneDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:06 PMChen LichtensteinDirector
Grant/Award
7,242—7,242(D)

View →

May 28, 2026Jun 1 8:03 PMBARER SOL JDirector
Grant/Award
10,863—10,863(D)

View →

May 28, 2026Jun 1 8:02 PMRoberto MignoneDirector
Grant/Award
7,242—7,242(D)

View →

May 14, 2026May 18 8:02 PMEvan LippmanEVP, Business Development
Option Exercise
85,849—74,008(D)

View →

Mar 5, 2026Mar 9 8:23 PMMark SabagSee "Remarks"
Option Exercise
15,723—47,170(D)

View →

Mar 5, 2026Mar 9 8:22 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
19,916—59,748(D)

View →

Mar 5, 2026Mar 9 8:19 PMAmir WeissChief Accounting Officer
Option Exercise
3,537—10,613(D)

View →

Mar 5, 2026Mar 9 8:18 PMRichard D FrancisPresident and CEO
Option Exercise
42,452—127,359(D)

View →

Mar 5, 2026Mar 9 8:16 PMChristine FoxEVP, U.S. Commercial
Option Exercise
17,819—53,459(D)

View →

Mar 5, 2026Mar 9 8:14 PMEric A HughesSee "Remarks"
Option Exercise
19,654—58,962(D)

View →

Mar 5, 2026Mar 9 8:12 PMRichard DaniellEVP, Europe Commercial
Option Exercise
17,295—51,887(D)

View →

Mar 5, 2026Mar 9 8:10 PMPlacid JoverSee "Remarks"
Option Exercise
14,150—42,453(D)

View →

Mar 5, 2026Mar 9 8:09 PMBrian SavageInterim Chief Legal Officer
Option Exercise
3,580—10,740(D)

View →

Mar 5, 2026Mar 9 8:05 PMMatthew ShieldsEVP, Global Operations
Option Exercise
17,295—51,887(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Option Exercise
50,223—100,446(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Grant/Award
136,736—136,736(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Option Exercise
53,973—40,923(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Grant/Award
33,424—33,424(D)

View →

Mar 4, 2026Mar 6 9:16 PMPlacid JoverSee "Remarks"
Grant/Award
37,982—37,982(D)

View →